BWLSA
ILMN icon

Blue Water Life Science Advisors’s Illumina ILMN Stock Holding History

Blue Water Life Science Advisors’s Portfolio ILMN Stock Details ILMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-34,063
Closed -$15.7M – 25
2021
Q2 		$15.7M Buy
34,063
+3,840
+13% +$1.55M 5.9% 7
2021
Q1 		$11.3M Hold
30,223
– – 5.52% 6
2020
Q4 		$10.9M Buy
+30,223
New +$9.63M 6.38% 7

Other funds holding ILMN

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Blue Water Life Science Advisors's ILMN Position: Q3 2021 in Review

Blue Water Life Science Advisors sold out of Illumina (ILMN) in Q3 2021, closing a stake of 34,063 shares — an estimated $15.7M sold.

Blue Water Life Science Advisors first reported a position in ILMN in Q4 2020 and held it in 3 quarters. The position peaked at $15.7M in Q2 2021. 1,072 funds tracked by Wall St. Rank hold ILMN as of Q3 2021.

  • Blue Water Life Science Advisors reported no remaining Illumina position as of Q3 2021 after selling out during the quarter.
  • Blue Water Life Science Advisors sold 34,063 Illumina shares in Q3 2021, an estimated $15.7M.
  • Blue Water Life Science Advisors first reported a position in Illumina in Q4 2020 and held it in 3 quarters.
  • Blue Water Life Science Advisors's Illumina position peaked at $15.7M in Q2 2021.
  • 1,072 funds tracked by Wall St. Rank held Illumina as of Q3 2021.

Based on Blue Water Life Science Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.